>
pdufa.bio

Rexlemestrocel-L

Updated ยทnext FDA decision on the calendar

Rexlemestrocel-L is a Mesoblast Ltd program. Its next catalyst is a Readout in Jul 2027. Every date links its source.

MESO catalyst hub

All upcoming FDA decision dates on the 2026 PDUFA calendar

About this program

Sponsor: Mesoblast Ltd (MESO). We track 1 catalyst event for this program: 1 upcoming and 0 in the record. A PDUFA date is the FDA's target date to complete review of a marketing application; a readout is the sponsor's expected date for clinical trial results. What a PDUFA date is · why we do not compare trial results across drugs.

Catalyst history

Readout · Jul 2027MESO

Questions

When is Rexlemestrocel-L's next FDA decision or readout?

The next tracked catalyst for Rexlemestrocel-L is a Readout in Jul 2027.

What happened at Rexlemestrocel-L's most recent FDA decision?

No FDA decision for Rexlemestrocel-L is in our archive yet.

Who makes Rexlemestrocel-L?

Mesoblast Ltd (MESO).

Where does this data come from?

FDA announcements, sponsor press releases and SEC filings; every date on this page links its source.